Concepedia

Jeffrey J. Jones

JJ

24

Publications

3.9K

Citations

19

H-Index

2002

Active since

Affiliations

University of Arkansas at Fayetteville(Current)

The Ohio State University

California Institute of Technology

Vanderbilt University

Mayo Clinic in Arizona

Jeffrey J. Jones is an author at University of Arkansas at Fayetteville specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

2002–2023

24

Publications

24

Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia

John C. Byrd, Jennifer R. Brown, Susan O’Brien et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765

Sarah E. M. Herman, Amber Gordon, Erin Hertlein et al. · Blood · 2011 · 789 citations · Full text

Phosphatidylinositol 3-kinase-δ inhibitor CAL-101 shows promising preclinical activity in chronic lymphocytic leukemia by antagonizing intrinsic and extrinsic cellular survival signals

Sarah E.M. Herman, Amber Gordon, Amy J. Wagner et al. · Blood · 2010 · 541 citations · Full text

CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain–engineered monoclonal antibody

Farrukh T. Awan, Rosa Lapalombella, Rossana Trotta et al. · Blood · 2009 · 126 citations · Full text

, , +19

Age-related matrix stiffening epigenetically regulates α-Klotho expression and compromises chondrocyte integrity

Hirotaka Iijima, Gabrielle Gilmer, Kai Wang et al. · Nature Communications · 2023 · 107 citations · Full text

Rows per page

1–5 of 24